Supplementary Table S3 from Clinical and Molecular Risk Factors in Extracranial Malignant Rhabdoid Tumors: Toward an Integrated Model of High-Risk Tumors
To assess use of external evidence for overall survival (OS) estimation in oncology single-technology appraisals (STAs) by the National Institute for Health and Care Excellence (NICE). STAs for oncolo
Fluorescent-labeled zebrafish RAS-induced embryonal rhabdomyosarcoma (ERMS) were created to facilitate in vivo imaging of tumor-propagating cells, regional tumor heterogeneity, and dynamic cell moveme
Development of effective treatment for amyotrophic lateral sclerosis (ALS) has been hampered by disease heterogeneity,a limited understanding of underlying pathophysiology and methodological desig